NCT04522674View on ClinicalTrials.gov

Platelet-Rich Plasma (PRP) for Treatment of Symptomatic Lumbar Facet Syndrome of the Spine

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 19, 2021

Primary Completion Date

April 28, 2022

Study Completion Date

April 28, 2022

Conditions
Platelet-Rich Plasma
Interventions
BIOLOGICAL

Autologous platelet rich plasma

0.5 mL autologous platelet rich plasma into a symptomatic osteoarthritic lumbar facet to treat back pain caused by lumbar facet syndrome

Trial Locations (1)

80045

University of Colorado School of Medicine Spine Center, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT04522674 - Platelet-Rich Plasma (PRP) for Treatment of Symptomatic Lumbar Facet Syndrome of the Spine | Biotech Hunter | Biotech Hunter